Controls | CT | Not CT | ANOVA * | |
---|---|---|---|---|
(n = 29) | (n = 41) | (n = 33) | ||
Activity count/min | 286 ± 87 | 221 ± 82 # | 232 ± 104 | F(100,2) = 4.684, p = 0.011 |
SD (% of mean) | 147 ± 20 | 159 ± 22 | 158 ± 26 | F(100,2) = 2.519, p = 0.086 |
RMSSD (% of mean) | 103 ± 16 | 116 ± 21 # | 113 ± 19 | F(100,2) = 4.654, p = 0.012 |
Active period duration | 9.6 ± 2.0 | 7.5 ± 2.5 # | 8.4 ± 2.4 | F(100,2) = 4.262, p = 0.017 |
Inactive period duration | 5.9 ± 1.0 | 6.2 ± 1.7 | 6.0 ± 1.3 | F(100,2) = 0.338, p = 0.714 |
Active/inactive duration | 1.55 ± 0.31 | 1.24 ± 0.33 # | 1.48 ± 0.68 | F(100,2) = 4.288, p = 0.016 |
Longest active sequence | 254 ± 166 | 193 ± 86 | 214 ± 160 | F(100,2) = 1.670, p = 0.193 |
Longest inactive sequence | 77 ± 19 | 211 ± 241 # | 160 ± 151 | F(100,2) = 4.969, p = 0.009 |
Active sequences ≥36 min | 6.5 ± 2.2 | 4.9 ± 2.5 # | 5.5 ± 2.3 | F(100,2) = 4.200, p = 0.018 |
Inactive sequences ≥21 min | 7.3 ± 2.3 | 6.2 ± 2.5 | 6.5 ± 2.3 | F(100,2) = 2.079, p = 0.130 |
Scaling exponent | ||||
Active periods | 0.733 ± 0.125 | 0.832 ± 0.142 # | 0.778 ± 0.123 | F(100,2) = 4.858, p = 0.010 |
Inactive periods | 0.825 ± 0.101 | 0.894 ± 0.129 | 0.881 ± 0.136 | F(100,2) = 2.794, p = 0.066 |